Partnering with Countries to Achieve Lymphatic Filariasis Elimination
After describing the function of WHO's GPELF, this technical brief outlines approaches used by Act | West to support LF endemic countries to achieve LF elimination, highlights key challenges across LF programs. The brief also describes how Act | West supports countries to address the challenges, share best practices and lessons learned, and sustain country progress.
Type
Brief or Technical Note
Year of publication
Disease
Lymphatic Filariasis
Country
Benin, Burkina Faso, Cameroon, Cote d’Ivoire, Ghana, Mali, Niger, Senegal, Sierra Leone
Focus Areas
Mass Drug Administration (MDA), Monitoring, Evaluation, Research, Learning and Adapting (MERLA)
Partners
FHI360, Helen Keller International